<p>(A) and (B) T47-D cells were exposed for 15 min to progesterone or MPA (both 100 nM) in the presence or absence of the ROCK-2 inhibitor, Y-27632 (Y - 10 µM) and moesin and phosphorylated moesin were assayed with western analysis. * = P<0.05 vs control, # = P<0.05 vs corresponding progestin. (C) T47-D cells were transfected with scrambled siRNA or ROCK-2 target siRNA for 48 h. ROCK-2 protein expression was detected by western blot. (D) Cells were exposed to 100 nM progesterone or MPA for 15 min after transfection with 100 nM target siRNA for ROCK-2 or scrambled siRNA for 48 h. Cell contents of wild-type or phosphorylated moesin are shown. (E) and (F) Cells were treated with progesterone or MPA (both 100 nM) for 15 min in the presence or a...
<p>(A) and (B) Cells were treated with progesterone or MPA (both 100 nM) for 48 h, in the presence o...
<p>T47-D (A) or MCF-7 (B) cells were exposed for 15 min to 10 nM E2 or to E2 conjugated to bovine se...
The widely reported conflicting effects of progestin on breast cancer suggest that the progesterone ...
<p>(A) T47-D cells were treated with progesterone or MPA (both 100 nM) for 15 min, in the presence o...
<p>(A) shows wild-type (ERK1/ERK2) or phosphorylated ERK 1/2 (P-ERK1/ERK2) during exposure to proges...
<p>(A) T47-D cells were treated for 15 minutes with P or MPA (both 100 nM), in the presence or absen...
<p>(A), (B) (C) and (D) show the time- and dose-dependent moesin activation in T47-D breast cancer c...
(B) Shows the concentration/effect curve of each progestin on moesin phosphorylation over a range of...
<p>Breast cancer cells were treated for 15 min with 10 nM E2 in the presence or absence of the ROCK-...
<p>T47-D (A and D) , MCF-7 (B and E) or MDA-MB-468 (C) cells were treated for 15 minutes with either...
Progesterone plays a role in breast cancer development and progression but the effects on breast can...
Progesterone plays a role in breast cancer development and progression but the effects on breast can...
<p>Steroid-deprived, growth synchronized ER+ T47-D cells were exposed to 10 nM E2, or 10 nM E2-BSA c...
<p>(A) and (B) T47-D cells were treated with progesterone or MPA (both 100 nM) for 24 h, in the pres...
<p><b>Copyright information:</b></p><p>Taken from "Comparative actions of progesterone, medroxyproge...
<p>(A) and (B) Cells were treated with progesterone or MPA (both 100 nM) for 48 h, in the presence o...
<p>T47-D (A) or MCF-7 (B) cells were exposed for 15 min to 10 nM E2 or to E2 conjugated to bovine se...
The widely reported conflicting effects of progestin on breast cancer suggest that the progesterone ...
<p>(A) T47-D cells were treated with progesterone or MPA (both 100 nM) for 15 min, in the presence o...
<p>(A) shows wild-type (ERK1/ERK2) or phosphorylated ERK 1/2 (P-ERK1/ERK2) during exposure to proges...
<p>(A) T47-D cells were treated for 15 minutes with P or MPA (both 100 nM), in the presence or absen...
<p>(A), (B) (C) and (D) show the time- and dose-dependent moesin activation in T47-D breast cancer c...
(B) Shows the concentration/effect curve of each progestin on moesin phosphorylation over a range of...
<p>Breast cancer cells were treated for 15 min with 10 nM E2 in the presence or absence of the ROCK-...
<p>T47-D (A and D) , MCF-7 (B and E) or MDA-MB-468 (C) cells were treated for 15 minutes with either...
Progesterone plays a role in breast cancer development and progression but the effects on breast can...
Progesterone plays a role in breast cancer development and progression but the effects on breast can...
<p>Steroid-deprived, growth synchronized ER+ T47-D cells were exposed to 10 nM E2, or 10 nM E2-BSA c...
<p>(A) and (B) T47-D cells were treated with progesterone or MPA (both 100 nM) for 24 h, in the pres...
<p><b>Copyright information:</b></p><p>Taken from "Comparative actions of progesterone, medroxyproge...
<p>(A) and (B) Cells were treated with progesterone or MPA (both 100 nM) for 48 h, in the presence o...
<p>T47-D (A) or MCF-7 (B) cells were exposed for 15 min to 10 nM E2 or to E2 conjugated to bovine se...
The widely reported conflicting effects of progestin on breast cancer suggest that the progesterone ...